3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
8
Breast Neoplasms
7
Lung Neoplasms
5
Prostatic Neoplasms
4
Malignant Solid Neoplasm
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Depression
2
Colonic Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Adenocarcinoma, Follicular
2
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Rectal Neoplasms
1
Interventions
fludarabine
4
fludarabine phosphate
3
asciminib
3
venetoclax
2
gilteritinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Idarubicin
2
Cytarabine
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
ponatinib
1
nilotinib
1
enasidenib
1
blinatumomab
1
aldesleukin
1
Thiotepa
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Melphalan
1
Interleukin-2
1
Imatinib Mesylate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Interviews as Topic
×
90 days
×
Clear all
No trials found.